CLINICAL_TRIALS
trial_result
· 2025-01-30
Clinical Trial Update: Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates indicate completed testing of fexinidazole for Human African trypanosomiasis due to Trypanosoma brucei rhodesiense, with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African, Sleeping Sickness | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-01-30